4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001567619-19-005674
EVP, Chief Financial Officer acquired 10,162 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LINDAHL RICHARD S · EVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-26 | Grant or award : show line 1 in the form | +5,081 | 16,615 | D |
| 2019-02-26 | Grant or award : show line 2 in the form | +5,081 | 21,696 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-26 | Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) | +20,321 | $61.01 | $1,239,784 | 20,321 | D |
Loading xslF345X03/doc1.xml…